MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 561.00
+9.50 (1.72%)
Nov 4, 2026, 5:29 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 8.4 billion as of November 4, 2026. It is the 10,863rd most valuable company in the world and the 145th biggest in Sweden. Its market cap has decreased by 5.30% in one year.
Market Cap
8.40B
Enterprise Value
8.57B
Revenue
2.37B
Global Rank
Country Rank
#145 Sweden
PE Ratio
30.65
ChartMarket Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 8.40B, an increase of 22,455.27%. That is a compound annual growth rate of 30.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 8.40B | 1.49% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 75.99B |
| Sectra AB | 62.96B |
| Elekta AB | 23.88B |
| Vitrolife AB | 15.64B |
| Nolato AB | 13.87B |
| Xvivo Perfusion AB | 6.33B |
| CellaVision AB | 4.77B |
| BICO Group AB | 1.70B |